Krka DD (FRA:KN8) Cyclically Adjusted FCF per Share: €10.23 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KN8 Krka DD FRA:KN8
71 GF Score
Price €265.00
GF Value €184.60
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krka DD Cyclically Adjusted FCF per Share?

Krka DD FRA:KN8 +2.91% 71 Cyclically Adjusted FCF per Share is €10.23 as of Jun. 2026. GuruFocus rates FRA:KN8 with a GF Score™ of 71/100 and a GF Value™ of €184.60 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Krka DD's adjusted free cash flow per share for the three months ended in Jun. 2026 was €3.603. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €10.23 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Krka DD's average Cyclically Adjusted FCF Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Krka DD was 10.90% per year. The lowest was 8.60% per year. And the median was 9.75% per year.

As of today (2026-07-28), Krka DD's current stock price is €265.00. Krka DD's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €10.23. Krka DD's Cyclically Adjusted Price-to-FCF of today is 25.90.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Krka DD was 28.99. The lowest was 13.03. And the median was 18.47.


Krka DD  (FRA:KN8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Krka DD's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=265.00/10.23
=25.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Krka DD was 28.99. The lowest was 13.03. And the median was 18.47.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Krka DD Cyclically Adjusted FCF per Share Related Terms


Krka DD Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Krka DD's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Cyclically Adjusted FCF per Share Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 8.65

Krka DD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.48 8.42 8.65 8.87 10.23

FRA:KN8 vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Krka DD's Cyclically Adjusted Price-to-FCF falls into.


FRA:KN8
71GF Score
Krka DD FRA:KN8
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Krka DD's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.603/333.9520*333.9520
=3.603

Current CPI (Jun. 2026) = 333.9520.

Krka DD Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 1.383 241.428 1.913
201612 -0.160 241.432 -0.221
201703 0.221 243.801 0.303
201706 1.900 244.955 2.590
201709 0.877 246.819 1.187
201712 0.602 246.524 0.815
201803 1.785 249.554 2.389
201806 0.963 251.989 1.276
201809 2.070 252.439 2.738
201812 1.321 251.233 1.756
201903 2.156 254.202 2.832
201906 1.936 256.143 2.524
201909 2.207 256.759 2.871
201912 1.254 256.974 1.630
202003 1.980 258.115 2.562
202006 3.250 257.797 4.210
202009 2.157 260.280 2.768
202012 1.525 260.474 1.955
202103 2.879 264.877 3.630
202106 1.541 271.696 1.894
202109 2.742 274.310 3.338
202112 2.907 278.802 3.482
202203 2.061 287.504 2.394
202206 2.936 296.311 3.309
202209 3.720 296.808 4.186
202212 3.286 296.797 3.697
202303 -0.066 301.836 -0.073
202306 1.883 305.109 2.061
202309 1.495 307.789 1.622
202312 -0.464 306.746 -0.505
202403 1.044 312.332 1.116
202406 3.587 314.175 3.813
202409 2.360 315.301 2.500
202412 0.985 315.605 1.042
202503 4.753 319.799 4.963
202506 2.004 322.561 2.075
202509 3.405 324.800 3.501
202512 3.934 324.054 4.054
202603 2.068 330.213 2.091
202606 3.603 333.952 3.603

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €10.23 mean?
Krka DD (FRA:KN8) has a Cyclically Adjusted FCF per Share of €10.23 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Krka DD and its competitors.
Is Krka DD's Cyclically Adjusted FCF per Share too high?
Krka DD's current Cyclically Adjusted FCF per Share is €10.23. Overall, Krka DD has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Krka DD's Cyclically Adjusted FCF per Share of €10.23 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Krka DD and its competitors. Krka DD's current Cyclically Adjusted FCF per Share is €10.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (FRA:KN8) is currently considered Significantly Overvalued. The stock's GF Value™ is €184.60, compared to a current price of €265.00 — trading 43.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €10.23. Krka DD's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Krka DD (FRA:KN8), the current Cyclically Adjusted FCF per Share is €10.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (FRA:KN8) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €265.00 is trading 43.6% above its estimated GF Value™ of €184.60. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for FRA:KN8:

  • Cyclically Adjusted FCF per Share: €10.23
  • GF Value™: €184.60 vs. price of €265.00 (43.6% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the FRA:KN8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
71GF Score

Get the complete analysis for FRA:KN8

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€265.00
Price
€184.60
GF Value